Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 1246

Status in the House for the 91st Legislature (2019 - 2020)

Description

Prescription Drug Price Transparency Act established, drug manufacturers required to submit drug price information to the commissioner of health, civil penalties provided, and report required.

Authors (35)

Actions

House

02/14/2019
Introduction and first reading, referred to Health and Human Services Policy
pg. 366 Intro
02/18/2019
Authors added Munson and Xiong, J.
pg. 412
02/27/2019
Motion to recall and re-refer, motion prevailed Commerce
pg. 635
03/04/2019
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
pg. 733a
03/11/2019
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
pg. 967
03/18/2019
Committee report, to adopt and re-refer to Ways and Means
pg. 1176
03/18/2019
04/03/2019
Author added Sandstede
pg. 1837
04/10/2019
Author added Moller
pg. 3105
05/13/2019
Author added Hornstein
pg. 5801
02/20/2020
Author stricken Munson
pg. 6280
02/26/2020
Authors added Her, Noor, and Dehn
pg. 6507
02/27/2020
Division action, to adopt as amended and return to Ways and Means
03/11/2020
Committee report, without further rec to amend, re-refer to Judiciary Finance and Civil Law Division
pg. 6944a
04/17/2020
Author stricken McDonald
pg. 7217
04/28/2020
Committee report, to adopt and re-refer to Ways and Means
pg. 7226
04/28/2020
Joint rule 2.03, Deadlines, re-referred to Rules and Legislative Administration
pg. 7226
04/28/2020
Committee report, to adopt and re-refer to Ways and Means
pg. 7289
04/28/2020
Joint rule 2.03 waived
pg. 7289
05/04/2020
Author added Bernardy
pg. 7947
05/05/2020
Author stricken Gruenhagen
pg. 8000
05/11/2020
Author added Cantrell
pg. 8356